Study Investigates Cannabis Withdrawal Symptoms

研究调查大麻戒断症状

2021-01-13 23:14:21 Ganjapreneur

本文共830个字,阅读需3分钟

A recent study published in the journal Addiction and led by a group of researchers from the University of Michigan and the VA Ann Arbor Health Care System highlights concerns around “cannabis withdrawal syndrome.” The study looks at two years of surveys from 527 registered medical cannabis patients in Michigan. In order to establish a baseline for the withdrawal symptoms, participants were asked if they suffered from fifteen different symptoms like trouble sleeping, nausea, or irritability after going a “significant time without cannabis.” Then, based on the number of symptoms they experienced, Survey participants were grouped into three categories — mild, moderate, or severe. According to the Michigan study, a “baseline” 41 percent were in the mild category, 34 percent had moderate symptoms and 25 percent had severe cannabis withdrawal symptoms. Over the two-year period, the researchers found that patients who had mild symptoms usually stayed in the category and were less likely to have an increase in withdrawals. Researchers found that those in the moderate category were more likely to have a decrease in withdrawals over time and at the end of the two-year study only 17 percent remained in the severe category. Additionally, they found after the first year that 13 percent had moved up a category and, after the second year, eight percent reported worsening symptoms. The severe group was made up of younger participants, “long-term” cannabis users, and people with reported mental health issues. Older cannabis patients were less likely to report increased cannabis withdrawal. “Some people report experiencing significant benefits from medical cannabis, but our findings suggest a real need to increase awareness about the signs of withdrawal symptoms developing to decrease the potential downsides of cannabis use, especially among those who experience severe or worsening symptoms over time.”  — Study lead Lara Coughlin, Ph.D., via Michigan Medicine She says patients may perceive cannabis with drawl symptoms as part of their underlying health issue and suggests possibly talking to their health care providers about other pain treatments like cognitive behavioral therapy. Some of the signs of cannabis withdrawal syndrome, besides a general craving, include, “anxiety, sleep difficulties, decreased appetite, restlessness, depressed mood, aggression, irritability, nausea, sweating, headache, stomach pain, strange dreams, increased anger and shakiness,” according to the report. End Authored By: Lukas is a freelance writer and medical cannabis activist who lives in Tacoma. When he’s not writing about cannabis or working to bring a better medical cannabis system to Washington, he likes to DJ, play adaptive sports and volunteer in his Tacoma community. He supports national legalization and the opening up of the medical cannabis market in all 50 states.
最近发表在《成瘾》杂志上的一项研究,由密歇根大学和弗吉尼亚州安娜堡卫生保健系统的一组研究人员牵头,强调了人们对大麻戒断综合征的担忧。这项研究对密歇根州527名注册的医用大麻患者进行了两年的调查。 为了建立戒断症状的基线,研究人员询问参与者在长时间不吸食大麻后是否会出现15种不同的症状,如失眠,恶心或易怒。然后,根据他们所经历的症状数量,调查参与者被分为轻度,中度或重度三类。 根据密歇根的研究,基线41%属于轻度类别,34%有中度症状,25%有严重的大麻戒断症状。 在这两年的时间里,研究人员发现,症状较轻的患者通常留在这一类别中,而且停药的可能性较小。研究人员发现,随着时间的推移,那些处于中度类别的人更有可能减少停药,而在两年的研究结束时,只有17%的人仍然处于重度类别。此外,他们发现,在第一年后,13%的人的症状上升,而在第二年后,8%的人的症状恶化。重度组由较年轻的参与者,长期吸食大麻者和有精神健康问题报告的人组成。年龄较大的大麻患者报告大麻戒断增加的可能性较小。 一些人报告说从医用大麻中获得了显著的好处,但我们的发现表明,确实需要提高对戒断症状发展迹象的认识,以减少大麻使用的潜在负面影响,尤其是那些经历严重或随着时间推移症状恶化的人。研究负责人Lara Coughlin博士,来自密歇根医学 她说,病人可能会觉得大麻带来的拖拉症状是他们潜在健康问题的一部分,并建议可能会与他们的医疗保健提供者讨论其他疼痛治疗,如认知行为疗法。 报告说,除了一般的渴求之外,大麻戒断综合症的一些症状还包括焦虑,睡眠困难,食欲下降,不安,情绪低落,攻击性,易怒,恶心,出汗,头痛,胃痛,奇怪的梦,愤怒加剧和颤抖。 结束 作者: 卢卡斯是一个自由撰稿人和医疗大麻活动家,住在塔科马。当他不写关于大麻的文章,也不努力把更好的大麻医疗系统带到华盛顿时,他喜欢做DJ,做适应性运动,在他的塔科马社区做志愿者。他支持全国合法化,并在所有50个州开放医用大麻市场。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文